Vir Biotechnology Inc (VIR)
7.34
-0.03
(-0.41%)
USD |
NASDAQ |
Dec 20, 16:00
7.24
-0.10
(-1.36%)
After-Hours: 20:00
Vir Biotechnology Shareholders Equity (Quarterly): 1.241B for Sept. 30, 2024
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Janux Therapeutics Inc | 656.10M |
| Biomarin Pharmaceutical Inc | 5.413B |
| Arbutus Biopharma Corp | 106.89M |
| GlycoMimetics Inc | 11.38M |
| FibroGen Inc | -243.67M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 1.498B |
| Total Liabilities (Quarterly) | 257.63M |
| Current Ratio | 8.938 |